Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 11:33 AM UTC
| NCT Number | NCT06463665 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | PHASE2 |
| Target Enrollment | 142 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Genelux Corporation |
| Last Updated on CT.gov | June 4, 2026 (Jun 4, 2026) |
As of July 18, 2026: Clinical trial NCT06463665 is currently recruiting participants. This phase2 study for lung cancer is actively seeking new participants at 15 locations across the United States. The study is sponsored by Genelux Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06463665 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06463665 was last updated Jun 4, 2026 (June 4, 2026). HelloStudys verifies this status automatically.